Skip to main content
. 2020 Jan 28;11(4):419–428. doi: 10.18632/oncotarget.27447

Table 2. Clinical characteristics of the patients with recurrent aGCT samples.

Sample number Age Site of recurrence Time interval (months) CHR. Aberrations GI
3 71 abdomen 60 -22q 1
11 67 abdomen 35 +8, +13, -2, -5, -11,-15,-18,-22 21
14 73 abdomen 84 +1q, +6, +10, +12 +20, -3q, -22q 17
20 76 missing data missing data None 0
22 75 missing data missing data nc nc
23 48 abdomen 47 -22q 1
26 63 pelvis, abdomen 176 +14, -22q 2
30 74 abdomen 96 +1q, 1
38 45 abdomen 84 None 0
39 74 lung 9 nc nc
40 79 abdomen 276 +1, +12, -21, -22 12
41 80 abdomen 288 +1q, +12, -19q, -21, -22 10
42 78 abdomen 264 +1q, +12, -21, -22 9
43 77 retroperitoneal area 252 +1q, +12, -21, -22 9
44 77 retroperitoneal area 252 +1, +12, -21, -22 12
45 73 abdomen 204 +12, -21, -22 8
46 73 abdomen 204 +12, -21, -22 8

The time interval (in months) between initial surgery and recurrence is given and primary + recurrent tumor pairs are indicated in color. CHR: chromosome; NC: not contributory; GI: genomic index.